Cargando…

Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue

Detalles Bibliográficos
Autores principales:	Loria, Rossella, Vici, Patrizia, Di Lisa, Francesca Sofia, Soddu, Silvia, Maugeri-Saccà, Marcello, Bon, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662166/ https://www.ncbi.nlm.nih.gov/pubmed/36387137 http://dx.doi.org/10.3389/fonc.2022.1063651

Ejemplares similares

Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
por: Loria, Rossella, et al.
Publicado: (2022)

Therapeutic Targeting of Cancer Stem Cells
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2011)

Biological and clinical implications of cancer stem cells in primary brain tumors
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013)

Emerging Biological Treatments for Uterine Cervical Carcinoma
por: Vici, Patrizia, et al.
Publicado: (2014)

Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021)

Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review
por: Ravegnini, Gloria, et al.
Publicado: (2022)

Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells
por: D’Eliseo, Donatella, et al.
Publicado: (2016)

Neoadjuvant Sequential Docetaxel Followed by High‐Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial
por: Pizzuti, Laura, et al.
Publicado: (2016)

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2013)

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study
por: Bon, Giulia, et al.
Publicado: (2023)

Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions
por: Takanen, Silvia, et al.
Publicado: (2022)

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
por: Krasniqi, Eriseld, et al.
Publicado: (2022)

Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer Survivors
por: Caprara, Greta, et al.
Publicado: (2022)

Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Sperati, Francesca, et al.
Publicado: (2013)

Corrigendum: Glycobiology of Neuroblastoma: Impact on Tumor Behavior, Prognosis, and Therapeutic Strategies
por: Berois, Nora, et al.
Publicado: (2014)

Corrigendum: Metastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic Approach
por: Fukuda, Keitaro, et al.
Publicado: (2018)

Corrigendum: ESR1 fusions and therapeutic resistance in metastatic breast cancer
por: Nagy, Zsuzsanna, et al.
Publicado: (2023)

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
por: Meng, Yuan, et al.
Publicado: (2021)

Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
por: Bon, Giulia, et al.
Publicado: (2016)

Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression
por: Messina, Beatrice, et al.
Publicado: (2023)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Intraoperative Ultrasound: Emerging Technology and Novel Applications in Brain Tumor Surgery
por: Giammalva, Giuseppe Roberto, et al.
Publicado: (2022)

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2020)

Cardiovascular Toxicities of Breast Cancer Treatment: Emerging Issues in Cardio-Oncology
por: Goyal, Sharad, et al.
Publicado: (2015)

Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
por: Bruni, Alessio, et al.
Publicado: (2021)

Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
por: Che, Li, et al.
Publicado: (2022)

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin
por: Zattarin, Emma, et al.
Publicado: (2022)

Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
por: Racanelli, Dominga, et al.
Publicado: (2020)

Corrigendum: Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer
por: Moreau, Michele, et al.
Publicado: (2020)

Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
por: Shi, Jingzhen, et al.
Publicado: (2020)

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors
por: Annovazzi, Alessio, et al.
Publicado: (2023)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
por: Grassadonia, Antonino, et al.
Publicado: (2018)

Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes
por: Doddato, Gabriella, et al.
Publicado: (2021)

DNA-PK as an Emerging Therapeutic Target in Cancer
por: Mohiuddin, Ismail S., et al.
Publicado: (2019)

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019)

Cuproptosis: emerging biomarkers and potential therapeutics in cancers
por: Wang, Min, et al.
Publicado: (2023)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Vici, Patrizia, et al.
Publicado: (2016)

SCD1, autophagy and cancer: implications for therapy
por: Ascenzi, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f4evop69gjtf9omi8a4soga5n5